(Q34337324)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22795500%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Focal therapy of prostate cancer: energies and procedures (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22795500%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22795500%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Serge Mordon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22795500%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Nacim Betrouni

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22795500%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

G Bozzini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22795500%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

P Colin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22795500%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

P Nevoux

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22795500%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

12 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22795500%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22795500%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22795500%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22795500%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

155-167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22795500%20AND%20SRC:MED&resulttype=core&format=json

Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Comparative effectiveness of minimally invasive vs open radical prostatectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Intensity-modulated radiation therapy: supportive data for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Robotic-assisted laparoscopic prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Screening and prostate-cancer mortality in a randomized European study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Radical prostatectomy versus watchful waiting in early prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Focal therapy in prostate cancer-report from a consensus panel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Preoperative prediction of multifocal prostate cancer and application of focal therapy: review 2007.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Biological determinants of cancer progression in men with prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: active surveillance and focal targeted therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Cryosurgery for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Design considerations for a novel MRI compatible manipulator for prostate cryoablation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Percutaneous cryoablation of small kidney tumours under magnetic resonance imaging guidance: medium-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Focal prostate cryoablation: initial results show cancer control and potency preservation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

The "male lumpectomy": focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

"Male lumpectomy": focal therapy for prostate cancer using cryoablation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

An evaluation of patient selection criteria on predicting progression-free survival after primary focal unilateral nerve-sparing cryoablation for prostate cancer: recommendations for follow up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

High intensity focused ultrasound: surgery of the future?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Focal therapy for localized prostate cancer: a phase I/II trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly. A feasibility study with 10 years follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

High intensity focused ultrasound (HIFU) for prostate cancer: current clinical status, outcomes and future perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Photodynamic therapy for prostate cancer--a review of current status and future promise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

The possible role of ionic species in selective biodistribution of photochemotherapeutic agents toward neoplastic tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Photodynamic therapy: principles and therapeutic indications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Diverse optical characteristic of the prostate and light delivery system: implications for computer modelling of prostatic photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

A model to estimate the outcome of prostate cancer photodynamic therapy with TOOKAD Soluble WST11

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Comparing and combining light dose fractionation and iron chelation to enhance experimental photodynamic therapy with aminolevulinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Fractionated versus standard continuous light delivery in interstitial photodynamic therapy of dunning prostate carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Implications of a pre-existing tumor hypoxic fraction on photodynamic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Science, medicine, and the future. New techniques in laser therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Initial human clinical experience with diode laser interstitial treatment of benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Interstitial laser coagulation of the prostate. An experimental study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Feasibility of 3.0T magnetic resonance imaging-guided laser ablation of a cadaveric prostate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

MR thermometry-based feedback control of laser interstitial thermal therapy at 980 nm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Image guided photothermal focal therapy for localized prostate cancer: phase I trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Focal laser interstitial thermotherapy (LITT) at 980 nm for prostate cancer: treatment feasibility in Dunning R3327-AT2 rat prostate tumour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Interstitial microwave thermal therapy for prostate cancer: method of treatment and results of a phase I/II trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Interstitial microwave thermoablation for localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

MRI and contrast-enhanced ultrasound monitoring of prostate microwave focal thermal therapy: an in vivo canine study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Transperineal radiofrequency interstitial tumor ablation of the prostate: correlation of magnetic resonance imaging with histopathologic examination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Pilot study of radiofrequency interstitial tumor ablation (RITA) for the treatment of radio-recurrent prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

CyberKnife stereotactic radiotherapy as monotherapy for low- to intermediate-stage prostate cancer: early experience, feasibility, and tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

External beam radiotherapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: a sequential dose escalation pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Dose escalation to the dominant intraprostatic lesion defined by sextant biopsy in a permanent prostate I-125 implant: a prospective comparative toxicity analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Simultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: early results of a phase I NCI study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Proton-beam therapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Irreversible electroporation: implications for prostate ablation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Magnetic nanoparticle hyperthermia for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

EAU guidelines on prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Candidate selection for prostate cancer focal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate--a 4-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Dynamic Contrast Enhanced, Pelvic Phased Array Magnetic Resonance Imaging of Localized Prostate Cancer for Predicting Tumor Volume: Correlation With Radical Prostatectomy Findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Innovations in prostate biopsy strategies for active surveillance and focal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011

Focal cryotherapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.05.011